Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center, composed of Memorial Hospital for Cancer and Allied Diseases and the Sloan-Kettering Institute, is dedicated to excellence in the prevention, treatment, and cure of cancer through patient care, research, and education. Memorial Hospital for Cancer and Allied Diseases provides patient care. Early detection, precise diagnosis, individually tailored treatment, and concern for a patient's needs are the hallmarks of the care provided.

We have long been a leader for cancer surgery. Our surgeons developed many of the methods that are commonly used to treat cancer today. Our doctors have developed new chemotherapy drugs, and have pioneered ways to make chemotherapy safer and more effective. Our staff uses the most advanced technologies to target radiotherapy precisely to tumor sites, making treatment as effective as possible while protecting healthy tissue.

Our experts work together to provide multimodality therapy, meaning that if necessary, we will treat your cancer with the ideal combination of therapies. We were the first to establish a Psychiatry Service to help cancer patients and their families. We were also the first to establish a service focused on alleviating cancer pain, and a genetic counseling service.

For more information, or to contact Memorial Sloan-Kettering Cancer Center, see their website at:

» Recent News

New Computerized Tool Predicts Chance of Breast Cancerís Spread
03 Dec 03 | Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have developed a new computerized tool called a nomogram that will help patients and their physicians calculate the likelihood of breast cancer spreading beyond the sentinel lymph nodes.

Dr. Larry Norton Named Deputy Physician-in-Chief for Breast Cancer Programs
01 Nov 03 | Memorial Sloan-Kettering Cancer Center is pleased to announce the appointment of Larry Norton, MD as Deputy Physician-in-Chief for Breast Cancer Programs. Dr. Norton formerly served as the Chief of the Division of Solid Tumor Oncology.

Targeted Lung Cancer Treatment Causes Tumor Regression in Some Patients
01 Jun 03 | A new study suggests that a drug called erlotinib (TarcevaTM) has promising activity in patients with bronchioloalveolar cell carcinoma (BAC), a type of non-small cell lung cancer generally considered to be resistant to chemotherapy.

MRI May Help Find Missed Breast Cancers in High Risk Women
01 Jun 03 | New research presented today at the annual meeting of the American Society of Clinical Oncology finds that Magnetic Resonance Imaging (MRI) is a highly sensitive screening tool that may detect breast cancers missed by mammograms.

PSA Test for Prostate Cancer Shown to Have Normal Fluctuation
28 May 03 | A PSA (prostate specific antigen) blood test is part of routine prostate cancer screening for most men over 50. If the test result shows a moderately elevated PSA level, a referral for a biopsy is usually recommended.

Scientists Identify Mechanism for Tumor Death by Radiation
16 May 03 | For more than 40 years, it has been accepted that radiation kills tumors by damaging their DNA and that other elements that are part of the tumor mass, such as connective tissue and blood vessels, are minimally affected by radiation or not at all.

Pioneering Community-Based Ralph Lauren Center for Cancer Care & Prevention Opens in Harlem
01 May 03 | Through an innovative partnership, The Ralph Lauren Center for Cancer Care and Prevention has opened its doors to provide individuals, many of whom are medically underserved, with access to the highest quality cancer screening and treatment services.

Northport Resident Joins Medical Oncology Staff at Suffolk Outpatient Center in Commack
17 Apr 03 | Northport resident John Joseph Fiore, MD, has joined the staff at Memorial Sloan-Kettering Cancer Center's Suffolk Outpatient Center as its newest full-time physician.

DNA-Based Vaccine Triples Survival for Dogs with Melanoma
08 Apr 03 | The options for treating advanced melanoma are limited - regardless of whether the patient is a dog or a human. Because this deadly cancer is virtually resistant to chemotherapy and radiation in its late stages, new approaches are being investigated.

Study Finds Risk for Lung Cancer Varies Among Smokers
19 Mar 03 | Smoking, the number one cause of preventable death in the United States, causes 130,000 lung cancer deaths each year. Many smokers are now considering screening with low-dose helical CT scans in the hope of diagnosing the disease early.

Nominations Sought for Paul Marks Prizes
12 Feb 03 | Nominations are currently being sought for the Paul Marks Prizes for Cancer Research. These awards, established by Memorial Sloan-Kettering Cancer Center two years ago, are named for Paul A. Marks, MD, President Emeritus of the Center.

Targeted Immunotherapy Eradicates Cancer in Mice
09 Feb 03 | Researchers have developed a novel approach to instruct immune cells to recognize and kill cancer cells in a mouse model. The investigators plan to apply this strategy in a clinical trial for patients with certain forms of leukemias and lymphomas.

New Chairman of Pathology Appointed
06 Feb 03 | Marc Rosenblum, MD, has been named Chairman of the Department of Pathology at Memorial Sloan-Kettering Cancer Center (MSKCC). An internationally recognized neuropathologist, Dr. Rosenblum has been with Sloan-Kettering since 1983.

Mutation in DKC1 Gene Can Cause Rare Aging Disease & Cancer
10 Jan 03 | A rare genetic syndrome, Dyskeratosis Congenita, may hold the key to understanding what causes premature aging and cancer. Recreating DC in genetically altered mice, researchers proved that the disorder was caused by mutations in the DKC1 gene.

New Web-Based Resource: About Herbs, Botanicals & Other Products
07 Jan 03 | A unique web-based resource about herbs, botanicals, and other products has been launched to provide medical practitioners, as well as the general public, access to comprehensive information about these products.

Timing of Chemotherapy Improves Survival in Breast Cancer
12 Dec 02 | New research shows that giving doses of chemotherapy more frequently in time, leads to a significant improvement in survival with no increase in toxicity in women with node-positive breast cancer.

Gene Essential for the Natural Killer Cell Response Against Cancer Identified
16 Oct 02 | Two parts of the body's immune system are critical for its normal functioning. One of these, the innate immune component, must defend the body against onslaughts from foreign substances it has never before seen.

Mechanism That Influences Cancer Cells to Die Revealed
02 Oct 02 | Research published in today's online version of Nature sheds light on why certain cancer cells die (apoptosis) in response to chemotherapy, while others stop proliferating (cytostasis) and try to repair the damaging effects of the drug.

Winner of the 2002 Lasker Award For Basic Research
22 Sep 02 | James E. Rothman, PhD, a cell biologist whose career has focused on elucidating the underlying mechanisms of transport within cells, is a winner of the 2002 Albert Lasker Award for Basic Research.

New Genetic Mutation Increases Risk for Colon Cancer
19 Sep 02 | A newly-identified genetic marker increases the risk for colorectal cancer approximately three-fold in individuals born with this mutation, according to a study published in the September 20 issue of Science.

2  3   next »



Home » Medical Research » Memorial Sloan-Kettering Cancer Center